APA (7th ed.) Citation

Smith, M. P., Brunton, H., Rowling, E. J., Ferguson, J., Arozarena, I., Miskolczi, Z., . . . Wellbrock, C. (2016). Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy. Cancer cell, 29(3), 270. https://doi.org/10.1016/j.ccell.2016.02.003

Chicago Style (17th ed.) Citation

Smith, Michael P., et al. "Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy." Cancer Cell 29, no. 3 (2016): 270. https://doi.org/10.1016/j.ccell.2016.02.003.

MLA (9th ed.) Citation

Smith, Michael P., et al. "Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy." Cancer Cell, vol. 29, no. 3, 2016, p. 270, https://doi.org/10.1016/j.ccell.2016.02.003.